Renal Transplant
Nephrology
8
Pipeline Programs
3
Companies
3
Clinical Trials
4
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
7
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
1100%
+ 3 programs with unclassified modality
On Market (4)
Approved therapies currently available
Competitive Landscape
3 companies ranked by most advanced pipeline stage
NovartisBASEL, Switzerland
2 programs1
1
EverolimusPhase 41 trial
Anti R-IL2 + CyclosporinePhase 3
Active Trials
Veloxis PharmaceuticalsNC - Cary
1 program1
Change from Prograf to Envarsus XRPhase 41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Veloxis PharmaceuticalsChange from Prograf to Envarsus XR
GC BiopharmaRituximab
NovartisEverolimus
Clinical Trials (3)
Total enrollment: 71 patients across 3 trials
Cognitive Outcomes in Stable Renal Transplant Patients Switched FromTacrolimus to Envarsus XR™
Start: Jun 2021Est. completion: Jan 2026
Phase 4Active Not Recruiting
IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies
Start: Jan 2019Est. completion: May 2022
Phase 4Completed
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
Start: Aug 2010Est. completion: Mar 201471 patients
Phase 4Completed
Related Jobs in Nephrology
Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery
AstraZeneca
Sweden - Gothenburg
1w ago
Associate Director – Nephrology Market Access Strategy
Biogen
Cambridge, MA
1w ago
$164K - $226K/yr
Director, Strategy & Operations-Nephrology Franchise
Biogen
Cambridge, MA
1w ago
$195K - $269K/yr
Medical Science Liaison, CardioRenal - Portland, OR
AstraZeneca
Portland - OR, US
1w ago
Vice President, Head of Renal Sales
Novartis
Field Non-Sales (USA)
1w ago
$274K - $510K/yr
Specialty Account Manager, Nephrology- South Houston, Texas
Amgen
Texas - Houston, US
1w ago
$155K - $184K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space